The common testing swabs for COVID-19 is oropharyngeal swabs and nasopharyngeal swabs.

In 2021, the global COVID-19 Testing Swabs market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 Testing Swabs status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 Testing Swabs development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global COVID-19 Testing Swabs Scope and Market Size
COVID-19 Testing Swabs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Testing Swabs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oropharyngeal Swabs
Nasopharyngeal Swabs
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Puritan
3M
Ossur
Formlabs
Carbon
Roche
1 Drop Inc
SolGent Co
Abbott
PerkinElmer, Inc
Diagnostic Hybrids, Inc
Hologic
COPAN Diagnostics Inc
LabCorp
Quidel
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co